Home Cart 0 Sign in  

[ CAS No. 1375465-91-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1375465-91-0
Chemical Structure| 1375465-91-0
Structure of 1375465-91-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1375465-91-0 ]

Related Doc. of [ 1375465-91-0 ]

Alternatived Products of [ 1375465-91-0 ]

Product Details of [ 1375465-91-0 ]

CAS No. :1375465-91-0 MDL No. :MFCD28347706
Formula : C14H14N4O2 Boiling Point : -
Linear Structure Formula :- InChI Key :LIIWIMDSZVNYHY-UHFFFAOYSA-N
M.W : 270.29 Pubchem ID :57381425
Synonyms :

Calculated chemistry of [ 1375465-91-0 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.21
Num. rotatable bonds : 5
Num. H-bond acceptors : 4.0
Num. H-bond donors : 3.0
Molar Refractivity : 72.13
TPSA : 87.14 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.08
Log Po/w (XLOGP3) : 1.15
Log Po/w (WLOGP) : 1.33
Log Po/w (MLOGP) : 1.13
Log Po/w (SILICOS-IT) : 1.18
Consensus Log Po/w : 1.37

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.35
Solubility : 1.2 mg/ml ; 0.00442 mol/l
Class : Soluble
Log S (Ali) : -2.57
Solubility : 0.72 mg/ml ; 0.00266 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.47
Solubility : 0.00924 mg/ml ; 0.0000342 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.05

Safety of [ 1375465-91-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1375465-91-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1375465-91-0 ]

[ 1375465-91-0 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1598426-03-9 ]
  • [ 1375465-91-0 ]
YieldReaction ConditionsOperation in experiment
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 10℃; for 2h; 4 Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) [0253] A solution of MeOH (1000 ml) was cooled to about 0-5° C. with stirring. NH2OH HCl (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5° C. for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10° C. for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HCl (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45° C. overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 10℃; for 2h; 4 Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) A solution of MeOH (1000 ml) was cooled to about 0-5° C. with stirring. NH2OH HCl (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5° C. for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10° C. for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HCl (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45° C. overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 10℃; for 2h; 4.D Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) A solution of MeOH (1000 ml) was cooled to about 0-5° C. with stirring. NH2OH HCl (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5° C. for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10° C. for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HCl (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45° C. overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 10℃; for 2h; 4.D Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) A solution of MeOH (1000 ml) was cooled to about 0-5° C. with stirring. NH2OH HCl (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5° C. for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10° C. for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HCl (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45° C. overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 0 - 10℃; for 3h; 4 Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) A solution of MeOH (1000 ml) was cooled to about 0-5° C. with stirring. NH2OH HCl (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5° C. for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10° C. for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HCl (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45° C. overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 0 - 10℃; for 2h; 4 Synthesis o fN-hydroxy-2-(( 1 -phenylcyclopropyl)amino)pyrimidine-5 -carboxamide (Compound D): (Compound D): A solution of MeOH(1000 ml) was cooled to about 0-5 °C with stirring.NH2OH HC1 (1107 g, 10 equiv.) was added, followed by careful addition ofNaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5 °C for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10 °C for two hours until compound 4 was consumed. The reactionmixture was adjusted to a pH of about 8.5-9 through addition of HC1 (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45 °C overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 0 - 10℃; 1 Synthesis of N-hvdroxy-2-((l-phenylcvclopropyl)amino)pyrimidine-5-carboxamide (Compound A): Synthesis of N-hvdroxy-2-((l-phenylcvclopropyl)amino)pyrimidine-5-carboxamide (Compound A): A solution of MeOH(1000 ml) was cooled to about 0-5 °C with stirring. NH2OH HC1 (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5 °C for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10 °C for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HC1 (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45 °C overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 10℃; for 2h; 4 Synthesis of N-hydroxy-2-(( 1 -phenylcyclopropyl)amino)pyrimidine-5 -carboxamide(Comnound D: A solution of MeOH(1000 ml) was cooled to about 0-5 °C with stirring.NH2OH HC1 (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5 °C for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10 °C for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HC1 (6N), resulting inprecipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45 °C overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 0 - 10℃; for 2h; 1.A Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound 1) 0120] A solution of MeOH (1000 mL) was cooled to about 0-5°C with stirring. NH2OH HCl (1107 g, 10 equiv) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv) The resulting mixture was stirred at 0-5°C for one hour and was filtered to remove the solid. Intermediate 4 (450 g, 1.0 equiv) was added to the reaction mixture in one portion and stirred at 10°C for two hours until intermediate 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HCl (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 mL) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45°C overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 0 - 10℃; for 3h; 14 Synthesis of N-hydroxy-2-((l-phenylcyclopropyl)amino)pyrimidine-5-carboxamide ( Compound D) A solution of MeOH(1000 ml) was cooled to about 0-5 °C with stirring. NH2OH HC1 (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5 °C for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10 °C for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HC1 (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45 °C overnight (340 g, 79% yield).
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 10℃; for 2h; 4 Synthesis of N-hvdroxy-2-((l-phenylcvclopropyl)amino)pyrimidine-5-carboxamide (Compound D) A solution of MeOH(1000 ml) was cooled to about 0-5 °C with stirring. H2OH HC1 (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5 °C for one hr., and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10 °C for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HC1 (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45 °C overnight (340 g, 79% yield)
79% With hydroxylamine hydrochloride; sodium methylate In methanol at 10℃; for 2h; 4 Synthesis of N-hydroxy-2-((1-phenylcyclopropyl)amino)pyrimidine-5-carboxamide (Compound D) A solution of MeOH(1000 ml) was cooled to about 0-5 °C with stirring. H2OH HCl (1107 g, 10 equiv.) was added, followed by careful addition of NaOCH3 (1000 g, 12.0 equiv.) The resulting mixture was stirred at 0-5 °C for one hr, and was filtered to remove the solid. Compound 4 (450 g, 1.0 equiv.) was added to the reaction mixture in one portion, and stirred at 10 °C for two hours until compound 4 was consumed. The reaction mixture was adjusted to a pH of about 8.5-9 through addition of HC1 (6N), resulting in precipitation. The mixture was concentrated under reduced pressure. Water (3000 ml) was added to the residue with intense stirring and the precipitate was collected by filtration. The product was dried in an oven at 45 °C overnight (340 g, 79% yield).

Reference: [1]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - US2015/99744, 2015, A1 Location in patent: Paragraph 0253
[2]Current Patent Assignee: DANA-FARBER CANCER INSTITUTE; BRISTOL-MYERS SQUIBB CO - US2015/105358, 2015, A1 Location in patent: Paragraph 0413
[3]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - US2015/105409, 2015, A1 Location in patent: Paragraph 0221
[4]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - US2015/105383, 2015, A1 Location in patent: Paragraph 0233
[5]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - US2015/150871, 2015, A1 Location in patent: Paragraph 0271
[6]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - WO2016/7423, 2016, A1 Location in patent: Page/Page column 42
[7]Current Patent Assignee: REGENACY PHARMACEUTICALS LLC - WO2016/90230, 2016, A1 Location in patent: Page/Page column 20
[8]Current Patent Assignee: UNIVERSITY OF MODENA AND REGGIO EMILIA - WO2016/87950, 2016, A1 Location in patent: Page/Page column 30
[9]Current Patent Assignee: REGENACY PHARMACEUTICALS LLC; BRISTOL-MYERS SQUIBB CO - US2017/114023, 2017, A1 Location in patent: Paragraph 0117; 0120
[10]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - WO2017/143237, 2017, A1 Location in patent: Paragraph 53; 54
[11]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO; H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE - WO2017/184774, 2017, A1 Location in patent: Page/Page column 48; 49
[12]Current Patent Assignee: DANA-FARBER CANCER INSTITUTE - WO2017/214565, 2017, A1 Location in patent: Page/Page column 38; 39
Same Skeleton Products
Historical Records